TCNNF
Price
$7.58
Change
+$0.33 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.46B
59 days until earnings call
TKPHF
Price
$30.70
Change
+$3.25 (+11.84%)
Updated
Sep 5 closing price
Capitalization
48.68B
Interact to see
Advertisement

TCNNF vs TKPHF

Header iconTCNNF vs TKPHF Comparison
Open Charts TCNNF vs TKPHFBanner chart's image
Trulieve Cannabis
Price$7.58
Change+$0.33 (+4.55%)
Volume$309.56K
Capitalization1.46B
Takeda Pharmaceutical
Price$30.70
Change+$3.25 (+11.84%)
Volume$381
Capitalization48.68B
TCNNF vs TKPHF Comparison Chart in %
Loading...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TCNNF vs. TKPHF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Hold and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (TCNNF: $7.58 vs. TKPHF: $30.70)
Brand notoriety: TCNNF and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TCNNF: 40% vs. TKPHF: 0%
Market capitalization -- TCNNF: $1.46B vs. TKPHF: $48.68B
TCNNF [@Pharmaceuticals: Generic] is valued at $1.46B. TKPHF’s [@Pharmaceuticals: Generic] market capitalization is $48.68B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than TCNNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCNNF’s TA Score shows that 4 TA indicator(s) are bullish while TKPHF’s TA Score has 7 bullish TA indicator(s).

  • TCNNF’s TA Score: 4 bullish, 5 bearish.
  • TKPHF’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, TKPHF is a better buy in the short-term than TCNNF.

Price Growth

TCNNF (@Pharmaceuticals: Generic) experienced а -13.86% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +11.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($48.7B) has a higher market cap than TCNNF($1.46B). TCNNF YTD gains are higher at: 46.233 vs. TKPHF (14.784). TKPHF has higher annual earnings (EBITDA): 1.13T vs. TCNNF (280M). TKPHF has more cash in the bank: 419B vs. TCNNF (393M). TCNNF has less debt than TKPHF: TCNNF (824M) vs TKPHF (4.51T). TKPHF has higher revenues than TCNNF: TKPHF (4.48T) vs TCNNF (1.19B).
TCNNFTKPHFTCNNF / TKPHF
Capitalization1.46B48.7B3%
EBITDA280M1.13T0%
Gain YTD46.23314.784313%
P/E RatioN/A53.14-
Revenue1.19B4.48T0%
Total Cash393M419B0%
Total Debt824M4.51T0%
FUNDAMENTALS RATINGS
TCNNF vs TKPHF: Fundamental Ratings
TCNNF
TKPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9589
PRICE GROWTH RATING
1..100
3650
P/E GROWTH RATING
1..100
1634
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (6) in the null industry is significantly better than the same rating for TCNNF (83). This means that TKPHF’s stock grew significantly faster than TCNNF’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that TKPHF’s stock grew similarly to TCNNF’s over the last 12 months.

TKPHF's SMR Rating (89) in the null industry is in the same range as TCNNF (95). This means that TKPHF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (36) in the null industry is in the same range as TKPHF (50). This means that TCNNF’s stock grew similarly to TKPHF’s over the last 12 months.

TCNNF's P/E Growth Rating (16) in the null industry is in the same range as TKPHF (34). This means that TCNNF’s stock grew similarly to TKPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCNNFTKPHF
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
48%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
43%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
43%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 17 days ago
38%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
57%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEMIX12.290.05
+0.41%
Allspring Emerging Growth Inst
GAOSX22.160.06
+0.27%
JPMorgan Global Allocation I
SECUX39.140.10
+0.26%
NAA Mid Growth A
MINRX37.13N/A
N/A
MFS International Intrinsic Value R1
PICMX63.29N/A
N/A
Virtus KAR Mid-Cap Growth I

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+4.55%
GTBIF - TCNNF
82%
Closely correlated
+4.55%
CURLF - TCNNF
78%
Closely correlated
+1.79%
VRNOF - TCNNF
76%
Closely correlated
+5.51%
CRLBF - TCNNF
76%
Closely correlated
+5.26%
TSNDF - TCNNF
75%
Closely correlated
+13.08%
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TCNNF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TCNNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
+11.86%
TCNNF - TKPHF
14%
Poorly correlated
+4.55%
VTRS - TKPHF
11%
Poorly correlated
+1.65%
SGIOY - TKPHF
9%
Poorly correlated
+2.98%
SFOSF - TKPHF
7%
Poorly correlated
N/A
RSCI - TKPHF
2%
Poorly correlated
N/A
More